India’s Regulators Indicate New Changes For Drug Access
This article was originally published in PharmAsia News
Executive Summary
The Indian government has set its sights on a wide band of health care reforms. From introducing restrictions on drug marketing practices to making generic drugs and diagnostics available for free, the vision is grand but execution issues could present hurdles.